Ziprasidone Hydrochloride

CAS 138982-67-9 13 current records 7 historicalSmall Molecule

Who holds supplier records for Ziprasidone Hydrochloride? 13 organisations hold a current record for Ziprasidone Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (10), Canada (1), Malta (1) and China (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Ziprasidone Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ziprasidone-hydrochloride

Reading the evidence

  • 13 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    10 of the 13 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 7 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (13)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Ziprasidone Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Ziprasidone Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (8)

Certificates of Suitability on the EDQM register for Ziprasidone Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 10 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. ShaoxingCN
CEP 2025-227 - Rev 00
Ziprasidone hydrochloride monohydrate
Sept 2026Inspected Mar 2025
Germany
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2012-131 - Rev 02
Ziprasidone hydrochloride monohydrate
May 2025—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
CEP 2011-196 - Rev 02
Ziprasidone hydrochloride monohydrate
May 2025—
CHROMO LABORATORIES INDIA PRIVATE LIMITED PashamylaramIN
CEP 2018-110 - Rev 02
Ziprasidone hydrochloride monohydrate
Jan 2025—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2013-217 - Rev 03
Ziprasidone hydrochloride monohydrate
Oct 2024—
Amino Chemicals LTD. MarsaMT
CEP 2010-358 - Rev 01
Ziprasidone hydrochloride monohydrate
Oct 2023Inspected Nov 2024
Malta
ZYDUS LIFESCIENCES LIMITED VadodaraIN
R1-CEP 2012-366 - Rev 01
Ziprasidone hydrochloride monohydrate
Jul 2022—
MEGAFINE PHARMA (P) LIMITED MumbaiIN
R1-CEP 2011-141 - Rev 00
Ziprasidone hydrochloride monohydrate
Feb 2018—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (7)

Organisations whose Type II DMFs for Ziprasidone Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 7 historical records
  • India · Inactive DMF 26045 · filed May 2012
  • Bachem SA, Succursale de Vionnaz
    Switzerland · Inactive DMF 25735 · filed Jan 2012
  • QILU TIANHE PHARMACEUTICAL CO LTD
    Inactive DMF 24837 · filed Mar 2011
  • India · Inactive DMF 24347 · filed Dec 2010
  • TEVA PHARMACEUTICALS INDUSTRIES LTD
    Inactive DMF 19005 · filed Dec 2005
  • India · Inactive DMF 18952 · filed Nov 2005
  • RANBAXY LABORATORIES LTD
    Inactive DMF 18042 · filed Jan 2005

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Ziprasidone Hydrochloride is an antipsychotic drug used mainly to treat schizophrenia and bipolar disorder. It works by modulating the effects of neurotransmitters in the brain, particularly serotonin and dopamine.

Chemical identity

IUPAC name
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrate;hydrochloride
Canonical SMILES
C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.O.Cl
InChIKey
ZCBZSCBNOOIHFP-UHFFFAOYSA-N
Synonyms
Geodon API, cp-88,059-1, cp-88059-1, cp-880591, geodon, zeldox, ziprasidone hydrochloride hydrate, ziprasidone hydrochloride monohydrate, ziprasidone hydrochloride, monohydrate

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Atypical Antipsychotic

Therapeutic areas

PsychiatryNeurology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Ziprasidone Hydrochloride?

13 organisations hold an active US FDA Type II Drug Master File or a CEP for Ziprasidone Hydrochloride: Dr. Reddy's Laboratories Ltd. (India), Apotex Inc. (Canada), Amino Chemicals Ltd (Malta), APITORIA PHARMA PRIVATE LTD (India), CHROMO LABORATORIES INDIA PRIVATE LTD (India), Macleods Pharmaceuticals Ltd. (India), MEGAFINE PHARMA P LTD (India) and Zydus Lifesciences Limited (India), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Ziprasidone Hydrochloride Drug Master Files are active?

Dr. Reddy's Laboratories Ltd. (DMF 21147, 17922), Apotex Inc. (DMF 18050, 33173), Amino Chemicals Ltd (DMF 20105, 27259), APITORIA PHARMA PRIVATE LTD (DMF 21012), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 33991), Macleods Pharmaceuticals Ltd. (DMF 25048), MEGAFINE PHARMA P LTD (DMF 23739) and Zydus Lifesciences Limited (DMF 20769) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Ziprasidone Hydrochloride records mean?

7 organisations have only inactive Type II DMFs for Ziprasidone Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Ziprasidone Hydrochloride have a European Certificate of Suitability?

Yes. 8 organisations hold a valid CEP for Ziprasidone Hydrochloride on the EDQM register, including ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. Shaoxing (CN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN), CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram (IN), DR. REDDY'S LABORATORIES LIMITED Hyderabad (IN) and Amino Chemicals LTD. Marsa (MT) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Ziprasidone Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Ziprasidone Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.